Clinical Identifiers and Pathogenic Significance of Pseudomonas aeruginosa Bacteremia, in Comparison with Klebsiella pneumoniae and Enterobacter species

참고문헌 (23)

1. "Pseudomonas aeruginosa", pp.2587~2615 (2005), Churchill Livingstone
2. "Prescribing guidelines for severe Pseudomonas infections", 49, pp.229~233 (2002)
3. "Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates", 33, pp.1859~1864 (2001)
4. "Inadequate antimicrobial treatment:an important determinant of outcome for hospitalized patients", 31, pp.131~138 (2000)
5. "Pseudomonas aeruginosa bacteremia:risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome", 37, pp.745~751 (2003)
6. "Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis", 115, pp.529~535 (2003)
7. "Adequacy of early empiric antibiotic treatment and survival in severe sepsis:experience from the MONARCS trial", 38, pp.284~288 (2004)
8. "Prognostic factors of pneumonia requiring admission to the intensive care unit", 107, pp.511~516 (1995)
9. "Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa:incidence,risk,and prognosis", 162, pp.1849~1858 (2002)
10. "Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa", 125, pp.607~616 (2004)
11. "Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s", 19, pp.915~925 (2000)
12. "Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer:retrospective analysis of 245 episodes", 160, pp.501~509 (2000)
13. "Epidemiology and outcome of Pseudomonas aeruginosa bacteremia with special emphasis on the influence of antimicrobial therapy Analysis of 189 episodes", 156, pp.2121~2126 (1996)
14. "Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia", 47, pp.2756~2764 (2003)
15. "Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa", 53, pp.18~24 (2003)
16. "Patients at risk for inappropriate antimicrobial therapy of bacteremia", 231, pp.371~4 (1992)
17. "Performance standards for antimicrobial disk susceptibility tests" (2000), National Committee for Clinical Laboratory Standards
18. "Antibacterial susceptibility tests : dilution and disk diffusion methods", pp.1526~1543 (1999), ASM Press
19. "APACHE II:a severity of disease classification system", 13, pp.818~29 (1985)
20. "Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients:clinical outcome and length of hospitalization", 34, pp.1600~1606 (2002)
21. "Bloodstream Infections Caused by Enterobacter Species:Predictors of 30- day mortality and Impact of Broad-Spectrum Cephalosporin Resistance on Outcome", 39, pp.812~818 (2004)
22. "Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies", 31, pp.705~711 (2000)
23. "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting", 118, pp.146~155 (2000)

관련 논문AI추천